BioLife CMO has 356 shares withheld for taxes

BIOLIFE SOLUTIONS’ chief marketing officer had a small number of shares withheld for taxes tied to RSU vesting and retains over 160,000 common shares.

Available on EDGAR 09/10/2026 - 04:51 PM EDT Accepted by SEC EDGAR 09/10/2026 - 04:50 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BIOLIFE SOLUTIONS INC (BLFS) reported that Chief Marketing Officer Todd Berard had 356 shares of common stock withheld on September 8, 2026 to satisfy his tax withholding obligations arising from the release of restricted stock units. The shares were withheld by the company rather than sold in the market, and Berard continues to hold 162,293 shares of BIOLIFE common stock directly after this tax-withholding disposition. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Tax Withholding: 356 shares

Tax Withholding 1 txn

Insider Berard Todd

Role Chief Marketing Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	356	$35.38	$13K

Holdings After Transaction: Common Stock — 162,293 shares (Direct)

Holdings Before and After: Common Stock, 162,649 to 162,293 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Key Figures

Shares withheld for taxes: 356 shares Transaction price per share: $35.38 per share Shares held after transaction: 162,293 shares +1 more

4 metrics

Shares withheld for taxes 356 shares Common stock withheld on September 8, 2026 to satisfy tax withholding obligations on RSU release

Transaction price per share $35.38 per share Value used for the 356 BIOLIFE common shares withheld for tax withholding

Shares held after transaction 162,293 shares Direct holdings of BIOLIFE SOLUTIONS common stock by Todd Berard following the tax-withholding disposition

Transaction direction 1 tax-withholding disposition One code F transaction reported as a disposition to satisfy tax obligations

Key Terms

restricted stock units, tax withholding obligations, withheld by the Issuer

3 terms

restricted stock units financial

"arose upon the release of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations"

withheld by the Issuer financial

"Represents the number of shares withheld by the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BIOLIFE SOLUTIONS INC (BLFS) report for Todd Berard?

BIOLIFE SOLUTIONS reported that Chief Marketing Officer Todd Berard had 356 shares of common stock withheld on September 8, 2026 to satisfy tax withholding obligations from the release of restricted stock units, rather than through an open-market sale.

Was the BLFS insider transaction a market sale of shares?

No. The filing states the 356 shares represent shares withheld by the issuer to satisfy Todd Berard’s tax withholding obligations upon RSU release, not an open-market sale of BIOLIFE SOLUTIONS common stock.

How many BLFS shares does Todd Berard hold after the tax-withholding transaction?

After the tax-withholding disposition, Chief Marketing Officer Todd Berard holds 162,293 shares of BIOLIFE SOLUTIONS common stock directly, according to the Form 4 filing.

What price per share was used for the BLFS tax-withholding transaction?

The Form 4 reports a transaction price of $35.38 per share for the 356 shares of BIOLIFE SOLUTIONS common stock withheld to cover Todd Berard’s tax withholding obligations from RSU vesting.

Was Todd Berard’s BLFS tax-withholding transaction under a Rule 10b5-1 plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan is reported for Todd Berard’s September 8, 2026 tax-withholding transaction in BIOLIFE SOLUTIONS common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berard Todd

(Last) (First) (Middle)

3303 MONTE VILLA PARKWAY

SUITE 310

(Street)

BOTHELL WASHINGTON 98021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOLIFE SOLUTIONS INC [ BLFS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		F		356(1)	D	$35.38	162,293	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Remarks:

	/s/ Todd Berard	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)